Managers / Q4 2021 · view latest →
PAYDEN & RYGEL
CIK 0000919219 · 333 SOUTH GRAND, 40TH FL, LOS ANGELES, CA, 90071 · 213-830-4255
Summary
Payden & Rygel reported $2.2B in U.S.-listed holdings across 126 positions for Q4 2021.
Its largest position, CVS, represents 2.4% of the portfolio.
Compared with Q3 2021, the fund opened 16 new positions and exited 17.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 81.4% · $1.8B
- REIT · 9.3% · $201M
- ETP · 7.0% · $150M
- ADR · 1.2% · $26M
- MLP · 1.2% · $25M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ETNEATON | NEW | +215.1K | 215.1K | +$37M | $37M |
| AMTAMERICAN TOWER | NEW | +120.9K | 120.9K | +$35M | $35M |
| ISHARES IBOXX H/Y CORP BOND ETF | NEW | +385.0K | 385.0K | +$33M | $33M |
| ADIANALOG DEVICES | NEW | +149.1K | 149.1K | +$26M | $26M |
| ENBENBRIDGE | NEW | +659.0K | 659.0K | +$26M | $26M |
| PPGPPG INDUSTRIES | NEW | +140.9K | 140.9K | +$24M | $24M |
| APDAIR PRODUCTS & CHEMICALS | NEW | +79.8K | 79.8K | +$24M | $24M |
| SUISUN COMMUNITIES | NEW | +106.2K | 106.2K | +$22M | $22M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.3B | 114 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.4B | 115 | Feb 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.2B | 113 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 113 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.2B | 125 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.2B | 124 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.3B | 122 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.4B | 135 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.4B | 131 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.7B | 122 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.9B | 136 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.7B | 136 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.7B | 138 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.0B | 128 | Apr 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.2B | 126 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.9B | 127 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.1B | 126 | Aug 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.2B | 120 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.0B | 133 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.7B | 124 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.6B | 115 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.4B | 115 | May 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.6B | 121 | Jan 31, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.5B | 118 | Oct 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.5B | 118 | Aug 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.4B | 119 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.